CRF1 Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence From

Total Page:16

File Type:pdf, Size:1020Kb

CRF1 Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence From bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 1 1 CRF1 receptor-dependent increases in irritability-like behavior during abstinence from 2 chronic intermittent ethanol vapor exposure 3 4 Adam Kimbrough, Ph.D., Giordano de Guglielmo, Ph.D., Jenni Kononoff, Ph.D., Marsida 5 Kallupi, Ph.D., Eric P. Zorrilla, Ph.D., Olivier George, Ph.D. 6 7 Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037 8 9 *Correspondence should be addressed to 10 Dr. Olivier George, 1Department of Neuroscience, The Scripps Research Institute, 10550 North 11 Torrey Pines Road, SP30-2400, La Jolla, CA 92037. E-mail: [email protected]. Phone: +1- 12 858-784-9039 ; Fax: 858-784-7405 13 14 This work was supported by National Institutes of Health grants AA006420, AA020608, 15 AA022977, and AA007456 and the Pearson Center for Alcoholism and Addiction Research. The 16 content is solely the responsibility of the authors and does not necessarily represent the official 17 views of the National Institutes of Health. 18 19 20 bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 2 21 Abstract 22 Background: In humans, emotional and physical signs of withdrawal from ethanol are 23 commonly seen. Many of these symptoms, including anxiety-like and depression-like behavior, 24 have been characterized in animal models of ethanol dependence. One issue with several current 25 behavioral tests measuring withdrawal in animal models is they are often not repeatable within 26 subjects over time. Additionally, irritability, one of the most common symptoms of ethanol 27 withdrawal in humans, has not been well characterized in animal models. The corticotropin- 28 releasing factor (CRF)-CRF1 receptor system has been suggested to be critical for the emergence 29 of anxiety-like behavior in ethanol dependence, but the role of this system in irritability-like 30 behavior has not been characterized. Methods: The present study compared the effects of 31 chronic intermittent ethanol vapor exposure (CIE)-induced ethanol dependence on irritability- 32 like behavior in rats using the bottle-brush test during acute withdrawal and protracted 33 abstinence. Rats were trained to self-administer ethanol in operant chambers and then either left 34 in a nondependent state or made dependent via CIE. Naive, nondependent, and dependent rats 35 were tested for irritability-like behavior in the bottle-brush test 8 h and 2 weeks into abstinence 36 from ethanol. A separate cohort of dependent rats was used to examine the effect of the specific 37 CRF1 receptor antagonist R121919 on irritability-like behavior. Results: Dependent rats 38 exhibited escalated ethanol intake compared with their own pre-CIE baseline and nondependent 39 rats. At both time-points of abstinence, ethanol-dependent rats exhibited increased aggressive- 40 like responses compared with naive and nondependent rats. R121919 blocked the increased 41 irritability-like behavior in dependent rats. Conclusions: The effect of R121919 to block 42 increased irritability-like behavior suggests that CRF plays an important role in this behavior, 43 similar to other negative emotional withdrawal symptoms. Quantifying and understanding the bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 3 44 molecular basis of irritability-like behavior may yield new insights into withdrawal from ethanol 45 and other drugs of abuse. 46 47 Keywords: ethanol, dependence, chronic intermittent ethanol, irritability, corticotropin-releasing 48 factor 49 50 bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 4 51 Introduction 52 Alcoholism is a chronic relapsing disorder associated with compulsive drinking, the loss 53 of control over intake, and the emergence of a negative emotional state during abstinence (Koob 54 et al., 2004, Koob and Volkow, 2010). In humans, the emotional and physical signs of ethanol 55 withdrawal include anxiety, irritability, mood swings, insomnia, tremors, convulsions, higher 56 blood pressure, accelerated pulse, accelerated breathing, accelerated heart rate, dehydration, and 57 delirium tremens (Schuckit et al., 1995, Finn and Crabbe, 1997). The emotional symptoms of 58 ethanol dependence, including anxiety-like behavior and depression-like behavior, can be 59 modeled in animals during ethanol dependence (Pleil et al., 2015, Marcinkiewcz et al., 2015, 60 Thorsell et al., 2007, Varlinskaya et al., 2017, Kallupi et al., 2014, Gilpin et al., 2012, Gilpin et 61 al., 2015, Heilig et al., 2010, Kliethermes et al., 2004, Pandey et al., 2015, Pandey et al., 2003, 62 Valdez et al., 2004, Valdez et al., 2002a, Ehlers et al., 2013, Vetreno et al., 2016, Rylkova et al., 63 2009, McClintick and Grant, 2016, Egli et al., 2012, Buck et al., 2014). An important challenge 64 for preclinical researchers is the fact that these tests are usually not repeatable within subjects 65 over time, which prevents conducting reliable longitudinal studies. Moreover, increased 66 irritability is a key negative emotional symptom that has been largely neglected. 67 Irritability is one of the most common withdrawal symptoms in humans (Lubman et al., 68 1983) and has been anecdotally noted during withdrawal in animal models but shown to be 69 difficult to quantify experimentally (Frye and Ellis, 1977, Riihioja et al., 1997, Riihioja et al., 70 1999, Woldbye et al., 2002, Becker, 2000). Thus, it is critical to characterize irritability-like 71 behavior during withdrawal and protracted abstinence from ethanol in dependent rats. 72 A commonly used method to study ethanol dependence and withdrawal is the chronic 73 intermittent ethanol (CIE) vapor exposure model (Kissler et al., 2014, Gilpin et al., 2008c, Gilpin bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 5 74 et al., 2008b, Staples et al., 2015, Leao et al., 2015, de Guglielmo et al., 2016, Kimbrough et al., 75 2017). Rats that are made dependent with CIE exhibit clinically-relevant blood ethanol levels 76 (BELs; 150-250 mg%), an increase in ethanol drinking when tested during early and protracted 77 withdrawal, and compulsive-like ethanol drinking (i.e., responding despite adverse 78 consequences; (Rogers et al., 1979, Roberts et al., 1996, Roberts et al., 2000, O'Dell et al., 2004, 79 Schulteis et al., 1995, Vendruscolo et al., 2012, Seif et al., 2013, Leao et al., 2015, Kimbrough et 80 al., 2017). Ethanol dependence that is induced by ethanol vapor results in withdrawal symptoms 81 during both acute withdrawal (somatic and motivational) and protracted abstinence 82 (motivational; (Macey et al., 1996, Sommer et al., 2008, Schulteis et al., 1995, Williams et al., 83 2012, Kallupi et al., 2014, Valdez et al., 2002b, Zhao et al., 2007, Vendruscolo and Roberts, 84 2014, de Guglielmo et al., 2017), but the effects of abstinence from CIE on irritability-like 85 behavior during withdrawal and after protracted abstinence has not yet been reported. 86 Converging lines of evidence suggest that recruitment of the brain corticotropin-releasing 87 factor (CRF)-CRF1 receptor system during withdrawal from CIE is critical for the emergence of 88 anxiety-like behavior (Valdez et al., 2002a, Sabino et al., 2006, Finn et al., 2007, Gilpin et al., 89 2008b, Richardson et al., 2008b, Richardson et al., 2008a), but the role of the CRF-CRF1 system 90 in irritability-like behavior during withdrawal remains to be demonstrated. In the present study, 91 we hypothesized that (1) abstinence from ethanol after the escalation of ethanol drinking using 92 the CIE model would increase irritability-like behavior in the bottle-brush test 8 h into 93 withdrawal and after 2 weeks of protracted abstinence (Riittinen et al., 1986, Lagerspetz and 94 Portin, 1968) and (2) the CRF1 receptor antagonist R121919 would reduce irritability-like 95 behavior during withdrawal. 96 bioRxiv preprint doi: https://doi.org/10.1101/159871; this version posted July 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Kimbrough and George 6 97 Materials and Methods 98 Animals 99 Adult male Wistar rats (Charles River), weighing 250-300 g at the beginning of the 100 experiments, were used. The rats were group housed, two per cage, in a temperature-controlled 101 (22°C) vivarium on a 12 h/12 h light/dark cycle (lights on at 10:00 PM) with ad libitum access to 102 food and water. All of the procedures were conducted in strict adherence to the National 103 Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by The 104 Scripps Research Institute Institutional Animal Care and Use Committee. 105 106 Operant ethanol self-administration 107 Two cohorts of rats were used in this experiment. One cohort of rats (n = 24) and an 108 additional cohort of rats (n = 16) were trained to self-administer ethanol. Both cohorts self- 109 administered 10% (w/v) ethanol during daily sessions in standard operant conditioning chambers 110 (Med Associates) until stable responding was maintained as previously described (de Guglielmo 111 et al., 2016, Leao et al., 2015, Kimbrough et al., 2017).
Recommended publications
  • About Emotions There Are 8 Primary Emotions. You Are Born with These
    About Emotions There are 8 primary emotions. You are born with these emotions wired into your brain. That wiring causes your body to react in certain ways and for you to have certain urges when the emotion arises. Here is a list of primary emotions: Eight Primary Emotions Anger: fury, outrage, wrath, irritability, hostility, resentment and violence. Sadness: grief, sorrow, gloom, melancholy, despair, loneliness, and depression. Fear: anxiety, apprehension, nervousness, dread, fright, and panic. Joy: enjoyment, happiness, relief, bliss, delight, pride, thrill, and ecstasy. Interest: acceptance, friendliness, trust, kindness, affection, love, and devotion. Surprise: shock, astonishment, amazement, astound, and wonder. Disgust: contempt, disdain, scorn, aversion, distaste, and revulsion. Shame: guilt, embarrassment, chagrin, remorse, regret, and contrition. All other emotions are made up by combining these basic 8 emotions. Sometimes we have secondary emotions, an emotional reaction to an emotion. We learn these. Some examples of these are: o Feeling shame when you get angry. o Feeling angry when you have a shame response (e.g., hurt feelings). o Feeling fear when you get angry (maybe you’ve been punished for anger). There are many more. These are NOT wired into our bodies and brains, but are learned from our families, our culture, and others. When you have a secondary emotion, the key is to figure out what the primary emotion, the feeling at the root of your reaction is, so that you can take an action that is most helpful. .
    [Show full text]
  • In This Issue
    July 2020 NEWS Post-Traumatic Stress Disorder (PTSD) Assessment and Treatment In this Issue: Guidelines for Pediatric Primary Upcoming Clinical Care Conversations 5 Clinical Conversation: May 26, 2020 Presented by Sylvia Krinsky, MD, Tufts Medical Center For some children, childhood is far from a carefree time; they Leadership: experience trauma which can disrupt development and lead John Straus, MD to post-traumatic stress disorder (PTSD). At the May Clinical Founding Director Conversation, Sylvia Krinsky, MD, MCPAP site director at Tufts Barry Sarvet, MD Medical Center, discussed how to address PTSD in the primary Medical Director care setting. Beth McGinn Types of trauma Program Manager There are three major types of trauma: Elaine Gottlieb • Discrete Trauma – examples include a car accident, injury, Contributing Writer medical procedure, or a single episode of physical or sexual assault, when life is filled with otherwise helpful and supportive people • Complex Trauma – series of repeated traumas usually in close interpersonal contexts, such as childhood abuse or neglect, witnessing domestic or community violence, or racism and chronic social adversities • Adverse Childhood Event – a term from the Adverse Childhood Experiences (ACE) study, referring to potentially traumatic events that can have an impact on physical and psychological health Discrete trauma is most recognized in the DSM-5, while ACE is more familiar to the medical community, says Dr. Krinsky. 1000 Washington St., Suite 310 One study reported in the Journal of the American Medical Boston, MA 02118 Association (JAMA) found that more than 90 percent of pediatric Email: [email protected] patients seen in a primary care pediatric clinic had experienced a traumatic exposure, and 25 percent met full or partial criteria for www.mcpap.org PTSD.
    [Show full text]
  • Understanding Children's Mental Health Disorders and the Impact On
    Understanding Children’s Mental Health Disorders and the Impact on Learning and Functioning 1 2 Introduction to Children’s Mental Health An Overview of Depression 3 Depression is Common Estimates of Incidence 1 % Preschoolers 2 % School age 5 % Adolescents 20 % Lifetime prevalence during adolescence (parallels adult life time prevalence) Birmaher et al., 2002 4 Risk and Reoccurrence Childhood Adolescent Later Onset Depression Adolescent Depression Depression Adult Depression 5 Depression is… a mood disorder a sleep and energy disorder a thinking disorder 6 Depression: Signs and Symptoms Mood Changes Behaviors MEANING Interpersonal Relationships Physical Changes Cognitive Changes School Performance 7 Mood Symptoms Sad Sadness Irritable “mood swings” Anhedonia loss of interest social withdrawal or Anhedonia Irritability isolation boredom 8 Physical Symptoms Sleep Difficulty either with too much or too little sleep Fatigue Appetite Change loss of appetite increased carbohydrate craving 9 Cognitive Symptoms Difficulty concentrating Increased distractibility and “spaciness” Decreased attention and focus 10 Cognitive Symptoms Worried, ruminating thoughts Worthlessness, low self-esteem, guilt Distortions, misperceptions, misinterpretations 11 Symptoms in Infants and Toddlers Mood – Excessive whining – Too little or too much crying – Withdrawn from cuddling, being held – Lack of interest in surroundings 12 Symptoms in Infants and Toddlers Physical – Sleep disturbance – Sad or flat facial expression – Little motor activity – Failure to grow and
    [Show full text]
  • Behavioral Interventions for Anxiety and Irritability in Children and Adolescents with Autism Spectrum Disorder
    Behavioral Interventions for Anxiety and Irritability in Children and Adolescents with Autism Spectrum Disorder Denis G. Sukhodolsky, Ph.D. Yale Child Study Center Disclosures • Research support: – NIMH R01 MH101514 – NIMH K01 MH079130 – NICHD R01 HD083881 • Book royalty: – The Guilford Press Autism Spectrum Disorder (ASD) • Core symptoms – Impairment in social interaction and communication – Restricted interests and repetitive behavior • Associated features – Cognitive impairment – Deficits in adaptive functioning – Anxiety – Disruptive behavior problems Anxiety in ASD • Excessive fearfulness • Changes in routines and social situations • Can be related to core ASD symptoms • Co-occurring anxiety disorders may be present • Social anxiety may be difficult to diagnose • Contributes to impairment in functioning Cognitive-Behavior Therapy for Anxiety CBT is a well-established intervention for anxiety in children without autism. Key components: education, emotion regulation, and exposure and response prevention. Short-term duration, 8 to 16 weekly sessions. Treatment is conducted with the child and includes parent involvement. Is CBT helpful for anxiety in ASD? Main Findings: • 8 randomized controlled studies of CBT for anxiety were located. • CBT was superior to waitlist on parent and clinician-rated anxiety. • Effect sizes were 1.19 for parent ratings, 1.21 for clinician ratings and 0.68 for child self-report. Sukhodolsky, Bloch, Panza, Reichow Pediatrics, 2013 Neural Mechanisms of CBT for anxiety in ASD Subjects: • 10 children with ASD and
    [Show full text]
  • Dysphoria As a Complex Emotional State and Its Role in Psychopathology
    Dysphoria as a complex emotional state and its role in psychopathology Vladan Starcevic A/Professor, University of Sydney Faculty of Medicine and Health Sydney, Australia Objectives • Review conceptualisations of dysphoria • Present dysphoria as a transdiagnostic complex emotional state and assessment of dysphoria based on this conceptualisation What is dysphoria? • The term is derived from Greek (δύσφορος) and denotes distress that is hard to bear Dysphoria: associated with externalisation? • “Mixed affect” leading to an “affect of suspicion”1,2 1 Sandberg: Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtl Medizin 1896; 52:619-654 2 Specht G: Über den pathologischen Affekt in der chronischen Paranoia. Festschrift der Erlanger Universität, 1901 • A syndrome that always includes irritability and at least two of the following: internal tension, suspiciousness, hostility and aggressive or destructive behaviour3 3 Dayer et al: Bipolar Disord 2000; 2: 316-324 Dysphoria: associated with internalisation? • Six “dysphoric symptoms”: depressed mood, anhedonia, guilt, suicide, fatigue and anxiety1 1 Cassidy et al: Psychol Med 2000; 30:403-411 Dysphoria: a nonspecific state? • Dysphoria is a “nonspecific syndrome” and has “no particular place in a categorical diagnostic system”1; it is neglected and treated like an “orphan”1 1 Musalek et al: Psychopathol 2000; 33:209-214 • Dysphoria “can refer to many ways of feeling bad”2 2 Swann: Bipolar Disord 2000; 2:325-327 Textbook definitions: dysphoria nonspecific, mainly internalising? • “Feeling
    [Show full text]
  • The Neuroscience of Animal Welfare: Theory 80-20
    Review Article The neuroscience of animal welfare: theory 80-20 La neurociencia del bienestar animal: teoría 80-20 Genaro A. Coria-Avila, DVM, PhD1*, Deissy Herrera-Covarrubias, BSc, MSc2 1Centro de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Ver., México 2Doctorado en Neuroetología, Universidad Veracruzana, Xalapa, Ver., México. Recibido: 28 de agosto de 2012 Aceptado: 16 de octubre de 2012 Puedes encontrar este artículo en: http://www.uv.mx/eneurobiologia/vols/2012/6/6.html Abstract Animal welfare is commonly regarded as the physical and psychological well-being of animals, fulfilled if animals are free: 1) from hunger, thirst and malnutrition, 2) from discomfort, 3) from pain, 4) to express normal behavior, and 5) from fear and distress. This paper is meant to provoke the reader to re-think the concept of welfare. Evidence indicates that animal welfare is not a constant state, but rather it must be fulfilled several times a day. A theory is proposed arguing that well-being occurs when the proportion of desiring and obtaining something occurs in a 80-20% proportion, respectively. The neurobiological bases of motivated behaviors are discussed to support a new view on animal welfare. Key words: Dopamine, Opioids, Environmental enrichment, Well-being, Desire, Reward. Resumen Comúnmente se considera al bienestar animal cuando los animales están bien física y psicológicamente. Esto se logra cuando están libres: 1) de hambre, sed y malnutrición, 2) de incomodidad, 3) de dolor, 4) para expresar conducta normal, 5) de miedo y estrés. Este artículo tiene la intención de provocar al lector para reconsiderar el concepto de bienestar animal.
    [Show full text]
  • Association of Irritability and Anxiety with the Neural Mechanisms of Implicit Face Emotion Processing in Youths with Psychopathology
    Supplementary Online Content Stoddard J, Tseng W-L, Kim P, et al. Association of irritability and anxiety with the neural mechanisms of implicit face emotion processing in youths with psychopathology. JAMA Psychiatry. Published online November 30, 2016. doi:10.1001/jamapsychiatry.2016.3282 eAppendix. Prior Research. eMethods 1. Participant Assessment. eMethods 2. Image Acquisition and Processing. eMethods 3. Estimating Neural Activation and Amygdala Functional Connectivity. eResults 1. ANX vs HV Only: A Comparison to a Prior Study. eResults 2. DMDD vs HV Only: A Comparison to a Prior Study. eResults 3. Analysis by Primary Diagnosis Instead of Anxiety and Irritability Dimensions. eResults 4. Cross Validation. eTable 1. Dimensional Measures by Primary Diagnosis. eTable 2. Excluded Participants. eTable 3. Details of Post Hoc Analyses of Medication Effects. eFigure 1. Positive Control of Activation. eFigure 2. Accuracy is Related to Irritability When Viewing the Higher Intensities of Anger. eFigure 3 Significant Connectivity Effects Not Depicted in Main Text. eFigure 4. Activation Maps of the Effect of ARI by Emotion on Activation. eReferences This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eAppendix: Prior Research Prior investigations involving youths with severe, chronic irritability (operationalized either as severe mood dysregulation (SMD)1-4 or DMDD5) suggest the neural basis of irritability-associated face-emotion processing impairments.2 Of note, these prior studies involved two categories of irritability-related disorders, bipolar disorder and SMD/DMDD, and were designed to investigate their shared or distinct pathophysiology.6 They generally found that chronic irritability is associated with aberrant neural responses to different face emotions in visual (e.g.
    [Show full text]
  • Understanding Grief
    Understanding grief A guide for those grieving the death of a loved one kp.org/wa © 2018 Kaiser Foundation Health Plan of Washington GP0002339-50-17 Contents Understanding the journey of grief | 2 5 common myths about grief | 3 What to expect from grief | 5 Anticipatory grief | 7 Grief attacks or memory embraces | 9 The work of grieving | 10 Self-care while you grieve | 11 Common questions about grief support groups | 13 Ways to be good to yourself | 16 When does grief become depression? | 18 Where to get help | 20 1 Understanding the 5 common myths journey of grief about grief Grief is a healing journey we travel Myth #1: Grief and mourning are the through the death of a loved one and same experience. back to wholeness. Understanding this Grief describes the thoughts and process and the intense emotions that feelings we experience when someone can accompany it may help you move we love dies. Mourning describes our toward a healthy recovery. While the outward expression of grief, like crying, journey through grief may be slow and talking about the person, or celebrating difficult, it can also be a strengthening anniversary dates. Different cultures have and growth-filled experience. different customs for mourning. We can’t control everything that happens to us or our loved ones during this lifetime. Myth #2: There is a predictable, orderly But we do have control over how we way that everyone experiences grief. respond to those experiences. We can Certain experiences are common among choose to live in sorrow and anger, or we people who are grieving.
    [Show full text]
  • Exploring Longitudinal Mechanisms of Irritability in Children: Implications for Cognitive-Behavioral Intervention
    BETH-00899; No of Pages 15; 4C: Available online at www.sciencedirect.com ScienceDirect Behavior Therapy xx (xxxx) xxx www.elsevier.com/locate/bt Exploring Longitudinal Mechanisms of Irritability in Children: Implications for Cognitive-Behavioral Intervention Spencer C. Evans Harvard University Jennifer B. Blossom Seattle Children’s Hospital and University of Washington School of Medicine Paula J. Fite University of Kansas depressive symptoms, anxiety, reactive aggression, opposi- Severe irritability is a common and clinically important tionality, intolerance of uncertainty, and poor emotion problem longitudinally associated with internalizing and coping. From T1 irritability to T2/T3 outcomes, mediation externalizing problems in children. To better understand was found for poor sadness coping leading to reactive these mechanisms and to inform treatment research, we tested aggression and oppositionality; poor anger coping to anxiety, cognitive-behavioral processes as candidate mediators in the depressive symptoms, and oppositionality; and intolerance of paths from irritability to later problems. Methods: A school uncertainty to anxiety. Results offer further evidence for sample (N = 238, 48% female, ages 8–10) was assessed at internalizing and externalizing outcomes of youth irritability ~6-month intervals in fall (T1) and spring (T2) of third to and new evidence suggesting underlying mechanisms. Irrita- fourth grade, and again the following fall (T3). Measures bility may confer risk for externalizing problems via poor assessed irritability (T1/predictor); anger and sadness sadness/anger coping, and for internalizing problems via poor coping, intolerance of uncertainty, and rumination; (T1– anger coping and intolerance of uncertainty. Theoretical T2/mediators); and anxiety, depressive symptoms, reac- models and psychosocial treatment should consider address- tive aggression, and oppositionality (T1–T3/outcomes).
    [Show full text]
  • Help for Anxiety and Panic Disorders
    Information O from Your Family Doctor Help for Anxiety and Panic Disorders What are generalized anxiety disorder • Numbness or tingling and panic disorder? • Feeling that your body or things around Generalized anxiety disorder (GAD for short) and you are not real panic disorder (PD for short) are different types • Fear of going crazy or losing control of anxiety, or worry. It is normal to sometimes • Fear of dying worry or feel panicked, but you might have GAD or PD if these feelings frequently affect your life. How are GAD and PD treated? People with GAD worry much more than It is important to tell your doctor if you are having normal about everyday things. People with symptoms of GAD or PD. Some symptoms can GAD also have at least three of these symptoms: also be signs of other serious problems. • Feeling keyed up or on edge Medicines and psychological or behavioral • Tire easily talk therapy are the two main treatments of • Trouble focusing GAD and PD. Many people do best when treated • Irritability with both medicine and therapy. Your doctor • Feeling tense might also talk to you about how to avoid • Trouble sleeping situations that trigger your panic or anxiety. People with PD have panic attacks, which Making lifestyle changes is often helpful. These are sudden feelings of fear or anxiety. Sometimes changes include getting more exercise, drinking panic attacks happen for a reason, like being in less coffee, or getting better sleep. Tell your a busy public place, but people with PD can also doctor what medicines you are taking because have a panic attack out of the blue.
    [Show full text]
  • Mood Changes in Multiple Sclerosis
    MOOD CHANGES IN MULTIPLE SCLEROSIS Acknowledgments The National Multiple Sclerosis Society and the Multiple Sclerosis Society of Canada wish to acknowledge the support of the physicians, researchers, therapists, nursing staff and support staff from the following institutions: • MS Center at Holy Name Medical Center, Teaneck, N.J. • Sunnybrook Health Sciences Centre, Toronto State • University of Washington, Seattle We’d also like to thank the following individuals for so graciously giving their time and sharing their stories with us: • Ann Marie Johnson • Maria Reyes-Velarde • David Rosen Author Laurie Budgar was the editor of Momentum, the magazine of the National MS Society, from 2012–2017. She authored the original Society book, “Mood and Cognition in MS: What You Can Do,” from which this publication is excerpted and updated. Budgar specializes in health-related writing and editing, and is also a certified speech-language pathologist. Preface Though clinicians noted mood changes associated with multiple sclerosis as early as the 19th century, symptoms associated with mood disorder have only recently begun to receive the same degree of attention from clinicians as physical symptoms. Mood disorder is a complex issue and despite greater awareness, continues to be under-diagnosed and under-treated. This “invisible symptom” can be a direct result of the disease process, and can change over time. We now understand that mood and physical functioning are intricately entwined, and treating one area often brings profound improvement to other aspects of an individual’s life—and to the lives of their families. We also now recognize that while changes in mood may not be readily apparent to outside observers, their impact on a person’s life can be profound, affecting physical, social, emotional, occupational and spiritual functioning.
    [Show full text]
  • Anxiety Disorders: Diagnosis & Treatment
    Anxiety Disorders: Diagnosis & Treatment David Liu MD, MS Health Sciences Assistant Clinical Professor UC Davis Department of Psychiatry and Behavior Sciences Disclosures • I have no financial relationships to disclose relating to the subject matter of this presentation Learning Objectives 1. Review the DSM-5 diagnostic criteria for Generalized Anxiety Disorder and Panic Disorder 2. Recognize differential diagnosis of GAD and Panic Disorder 3. Appreciate common co-morbidities to Anxiety disorders 4. Understand approach towards management and treatment options for Anxiety disorders in the primary care setting Primary Care is the ‘De Facto’ Mental Health System What is Anxiety? Begins as ordinary, day-to-day Begins to effect situation. daily life Excessive DSM-5 Diagnostic Criteria for Generalized Anxiety Disorder A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months, about a number of events or activities (such as work or school performance) B. The individual finds it difficult to control the worry. C. The anxiety and worry are associated with three (or more) of the following six symptoms (With at least some symptoms having been presents for more days than not for the past 6 months). Note: Only one item is required in children – 1. Restlessness or feeling keyed up or on edge. – 2. Being easily fatigued. – 3. Difficulty concentrating or mind going blank. – 4. Irritability. – 5. Muscle tension. – 6. Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying sleep) DSM-5 DSM-5 Diagnostic Criteria for Generalized Anxiety Disorder (cont.) D. The anxiety, worry, or physical symptoms cause clinically significant distress or impairment in social occupational, or other important areas of functioning.
    [Show full text]